- Home
- MITK vs CMRX Comparison
MITK vs CMRX Comparison
Compare MITK & CMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MITK
- CMRX
- Stock Information
- Founded
- MITK 1983
- CMRX 2000
- Country
- MITK United States
- CMRX United States
- Employees
- MITK N/A
- CMRX N/A
- Industry
- MITK Computer peripheral equipment
- CMRX Biotechnology: Pharmaceutical Preparations
- Sector
- MITK Technology
- CMRX Health Care
- Exchange
- MITK Nasdaq
- CMRX Nasdaq
- Market Cap
- MITK 463.1M
- CMRX 394.1M
- IPO Year
- MITK N/A
- CMRX 2013
- Fundamental
- Price
- MITK $9.31
- CMRX $5.15
- Analyst Decision
- MITK Strong Buy
- CMRX Strong Buy
- Analyst Count
- MITK 4
- CMRX 2
- Target Price
- MITK $12.88
- CMRX $8.50
- AVG Volume (30 Days)
- MITK 565.2K
- CMRX 1.7M
- Earning Date
- MITK 02-10-2025
- CMRX 03-07-2025
- Dividend Yield
- MITK N/A
- CMRX N/A
- EPS Growth
- MITK N/A
- CMRX N/A
- EPS
- MITK 0.10
- CMRX N/A
- Revenue
- MITK $172,420,000.00
- CMRX $159,000.00
- Revenue This Year
- MITK $3.75
- CMRX N/A
- Revenue Next Year
- MITK $10.80
- CMRX $1,690.28
- P/E Ratio
- MITK $96.64
- CMRX N/A
- Revenue Growth
- MITK 5.28
- CMRX N/A
- 52 Week Low
- MITK $7.35
- CMRX $0.75
- 52 Week High
- MITK $16.24
- CMRX $5.53
- Technical
- Relative Strength Index (RSI)
- MITK 36.05
- CMRX 76.25
- Support Level
- MITK $9.06
- CMRX $3.94
- Resistance Level
- MITK $10.47
- CMRX $5.53
- Average True Range (ATR)
- MITK 0.36
- CMRX 0.30
- MACD
- MITK -0.13
- CMRX 0.07
- Stochastic Oscillator
- MITK 12.14
- CMRX 78.29
About MITK Mitek Systems Inc.
Mitek Systems Inc is engaged in the development, sale, and service of proprietary software solutions related to mobile imaging. The firm is a software development company with expertise in artificial intelligence, and machine learning. It serves more than 7,900 financial services organizations, financial technology (fintech) brands, telecommunications companies, and marketplace brands across the globe. The company's Mobile Deposit solution is used by consumers for mobile check deposits. The company's Mobile Verify verifies a user's identity online enabling organizations to build safer digital communities, whereas CheckReader enables financial institutions to automatically extract data from a check image received across any deposit channel - branch, ATM, RDC, and mobile.
About CMRX Chimerix Inc.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.